Munhoz, J., Newell, M., Goruk, S., Ghosh, S., Patel, D., Joy, A. A., . . . Field, C. J. Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial. BMC.
Chicago Style (17th ed.) CitationMunhoz, Jaqueline, et al. Docosahexaenoic Acid (DHA) Supplementation Attenuates Changes in the Concentration, Phenotype, and Response of Immune Peripheral Blood Cells in Breast Cancer Patients Undergoing Neoadjuvant Therapy. Secondary Findings from the DHA-WIN Trial. BMC.
MLA (9th ed.) CitationMunhoz, Jaqueline, et al. Docosahexaenoic Acid (DHA) Supplementation Attenuates Changes in the Concentration, Phenotype, and Response of Immune Peripheral Blood Cells in Breast Cancer Patients Undergoing Neoadjuvant Therapy. Secondary Findings from the DHA-WIN Trial. BMC.